<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">patients </span>
   <span class="font28">COVID- </span>
   <span class="font17">cardiac </span>
   <span class="font16">myocardial </span>
   <span class="font16">disease </span>
   <span class="font16">coronavirus </span>
   <span class="font15">cardiovascular </span>
   <span class="font15">associated </span>
   <span class="font15">injury </span>
   <span class="font15">acute </span>
   <span class="font15">{border-style </span>
   <span class="font14">px;} </span>
   <span class="font14">risk </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">COVID-. </span>
   <span class="font14">hospitalized </span>
   <span class="font13">complications </span>
   <span class="font13">higher </span>
   <span class="font13">respiratory </span>
   <span class="font13">increased </span>
   <span class="font13">novel </span>
   <span class="font13">troponin </span>
   <span class="font13">.%, </span>
   <span class="font13">ACE- </span>
   <span class="font13">CVD </span>
   <span class="font13">online </span>
   <span class="font12">COVID-, </span>
   <span class="font12">However, </span>
   <span class="font12">compared </span>
   <span class="font12">heart </span>
   <span class="font12">severe </span>
   <span class="font12">study </span>
   <span class="font12">syndrome </span>
   <span class="font12">viral </span>
   <span class="font12">patients, </span>
   <span class="font12">ACS </span>
   <span class="font12">caused </span>
   <span class="font12">clinical </span>
   <span class="font12">comorbidities </span>
   <span class="font12">data </span>
   <span class="font12">increase </span>
   <span class="font12">involving </span>
   <span class="font12">levels </span>
   <span class="font12">presence </span>
   <span class="font12">px; </span>
   <span class="font12">secondary </span>
   <span class="font12">underlying </span>
   <span class="font12">{font-family </span>
   <span class="font11">Mar </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">ahead </span>
   <span class="font11">angiotensin </span>
   <span class="font11">coronary </span>
   <span class="font11">font-size </span>
   <span class="font11">incidence </span>
   <span class="font11">inflammatory </span>
   <span class="font11">mortality </span>
   <span class="font11">myocarditis </span>
   <span class="font11">pandemic </span>
   <span class="font11">patient </span>
   <span class="font11">prevalence </span>
   <span class="font11">(COVID-) </span>
   <span class="font11">(Fig.Ã‚ </span>
   <span class="font11">Apr </span>
   <span class="font11">DM, </span>
   <span class="font11">HTN </span>
   <span class="font11">care </span>
   <span class="font11">double; </span>
   <span class="font11">elevated </span>
   <span class="font11">evidence </span>
   <span class="font11">factors </span>
   <span class="font11">failure </span>
   <span class="font11">health </span>
   <span class="font11">infection </span>
   <span class="font11">mechanisms </span>
   <span class="font11">new </span>
   <span class="font11">pre-existing </span>
   <span class="font11">prior </span>
   <span class="font11">respectively. </span>
   <span class="font11">significantly </span>
   <span class="font11">use </span>
   <span class="font11">Acute </span>
   <span class="font11">March </span>
   <span class="font11">Med </span>
   <span class="font11">SARS </span>
   <span class="font11">Wuhan, </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">case </span>
   <span class="font11">cases </span>
   <span class="font11">cells </span>
   <span class="font11">characteristics </span>
   <span class="font11">common </span>
   <span class="font11">high </span>
   <span class="font11">likely </span>
   <span class="font11">lung </span>
   <span class="font11">management </span>
   <span class="font11">occur </span>
   <span class="font11">print, </span>
   <span class="font11">solid; </span>
   <span class="font11">state </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(%) </span>
   <span class="font11">Ang-II </span>
   <span class="font11">April </span>
   <span class="font11">Armed </span>
   <span class="font11">BNP </span>
   <span class="font11">CVD, </span>
   <span class="font11">Cardiol </span>
   <span class="font11">Cardiol./jamacardio..Published </span>
   <span class="font11">Cardiovascular </span>
   <span class="font11">Elsevier </span>
   <span class="font11">Forces </span>
   <span class="font11">HTN, </span>
   <span class="font11">Heart </span>
   <span class="font11">India </span>
   <span class="font11">S-()- </span>
   <span class="font11">Thus, </span>
   <span class="font11">analysis </span>
   <span class="font11">appropriate </span>
   <span class="font11">arrhythmias </span>
   <span class="font11">arrhythmias, </span>
   <span class="font11">available </span>
   <span class="font11">biomarkers </span>
   <span class="font11">bold </span>
   <span class="font11">cause </span>
   <span class="font11">centre </span>
   <span class="font11">cerebrovascular </span>
   <span class="font11">confirmed </span>
   <span class="font11">courier; </span>
   <span class="font11">crucial </span>
   <span class="font11">cytokine </span>
   <span class="font11">develop </span>
   <span class="font11">developing </span>
   <span class="font11">effect </span>
   <span class="font11">elevation </span>
   <span class="font11">em; </span>
   <span class="font11">enzyme </span>
   <span class="font11">hospital </span>
   <span class="font11">infarction </span>
   <span class="font11">injury. </span>
   <span class="font11">involvement </span>
   <span class="font11">onset </span>
   <span class="font11">outcomes </span>
   <span class="font11">patients. </span>
   <span class="font11">pt;} </span>
   <span class="font11">receptors, </span>
   <span class="font11">recorded </span>
   <span class="font11">reports </span>
   <span class="font11">resource </span>
   <span class="font11">result </span>
   <span class="font11">retrospective </span>
   <span class="font11">revealed </span>
   <span class="font11">rise </span>
   <span class="font11">thrombotic </span>
   <span class="font11">type </span>
   <span class="font11">various </span>
  </p>
 </body>
</html>
